Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Accumulated Expenses (2016 - 2026)

Avanos Medical's Accumulated Expenses history spans 13 years, with the latest figure at $91.3 million for Q4 2025.

  • On a quarterly basis, Accumulated Expenses changed 0.0% to $91.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $91.3 million, a 0.0% change, with the full-year FY2025 number at $91.3 million, changed 0.0% from a year prior.
  • Accumulated Expenses hit $91.3 million in Q4 2025 for Avanos Medical, up from $74.8 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for AVNS hit a ceiling of $97.8 million in Q4 2022 and a floor of $59.6 million in Q3 2021.
  • Historically, Accumulated Expenses has averaged $79.1 million across 5 years, with a median of $78.7 million in 2021.
  • Biggest five-year swings in Accumulated Expenses: plummeted 32.2% in 2021 and later soared 43.61% in 2022.
  • Tracing AVNS's Accumulated Expenses over 5 years: stood at $68.1 million in 2021, then soared by 43.61% to $97.8 million in 2022, then dropped by 4.7% to $93.2 million in 2023, then dropped by 2.04% to $91.3 million in 2024, then changed by 0.0% to $91.3 million in 2025.
  • Business Quant data shows Accumulated Expenses for AVNS at $91.3 million in Q4 2025, $74.8 million in Q3 2025, and $66.0 million in Q2 2025.